Cell-enhancement strategies for the treatment of ischemic heart disease

Nature Clinical Practice Cardiovascular Medicine

Volumn 4, Issue SUPPL. 1, 2007, Pages

  Seeger, Florian H ^a   Zeiher, Andreas M ^a   Dimmeler, Stefanie ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; AVE 9488; C REACTIVE PROTEIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLYCOGEN SYNTHASE KINASE 3BETA; GROWTH FACTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTEGRIN LINKED KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PROTEIN KINASE B; SOMATOMEDIN C; STROMAL CELL DERIVED FACTOR 1; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG; VASCULOTROPIN;

ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CELL BASED GENE THERAPY; CELL COUNT; CELL FUNCTION; CELL HOMING; CELL SURVIVAL; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; ENHANCER REGION; ENZYME ACTIVATION; ENZYME INHIBITION; EXPERIMENTAL STUDY; GENE DELIVERY SYSTEM; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; NONHUMAN; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL;

ENDOTHELIAL CELLS; GENE THERAPY; HUMANS; MYOCARDIAL ISCHEMIA; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE SYNTHASE TYPE III; STEM CELL TRANSPLANTATION;

EID: 33846496127     PISSN: 17434297     EISSN: 17434300     Source Type: Journal    
DOI: 10.1038/ncpcardio0734     Document Type: Article

References (23)

1. Dimmeler S et al. (2005) Unchain my heart: The scientific foundations of cardiac repair. J Clin Invest 115: 572-683
2. Vasa M et al. (2001) Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89: E1-7
3. Tepper OM et al. (2002) Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106: 2781-2786
4. + and endothelial progenitor cells in patients with various degrees of congestive heart failure. Circulation 110: 1209-1212
5. Heeschen C et al. (2004) Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 109: 1615-1622
6. Murasawa S et al. (2002) Constitutive human telomerase reverse transcriptase expression enhances regenerative properties of endothelial progenitor cells. Circulation 106: 1133-1139
7. Mangi AA et al. (2003) Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 9: 1195-1201
8. Choi JH et al. (2004) Augmentation of therapeutic angiogenesis using genetically modified human endothelial progenitor cells with altered glycogen synthase knase-3[beta] activity. J Biol Chem 279: 49430-49438
9. Cho HJ et al. (2005) Regulation of endothelial cell and endothelial progenitor cell survival and vasculogenesis by integrin-linked kinase. Arterioscler Thromb Vasc Biol 25: 1154-1160
10. Gnecchi M et al. (2005) Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 11: 367-368
11. Iwaguro H et al (2002) Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation 105: 732-738
12. Kong D et al. (2004) Enhanced inhibition of neointimal hyperplasia by genetically engineered endothelial progenitor cells. Circulation 109: 1769-1775
13. Dimmeler S et al. (2001) HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest 108: 391-397
14. Walter DH et al. (2002) Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 105: 3017-3024
15. Sasaki K et al. (2006) Ex vivo pretreatment of bone marrow mononuclear cells with endothelial NO synthase enhancer AVE9488 enhances their functional activity for cell therapy. Proc Natl Acad Sci USA 103: 14537-14541
16. Verma S et al. (2004) C-reactive protein attenuates endothelial progenitor call survival, differentiation, and function: Further evidence of a mechanistic link between C-reactive protein and cardiovascular disease. Circulation 109: 2058-2067
17. Seeger FH et al. (2005) p38 mitogen-activated protein kinase downregulates endothelial progenitor cells. Circulation 111: 1184-1191
18. Hofmann M et al. (2005) Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 111: 2198-2202
19. Ceradini DJ et al. (2004) Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 10: 858-864
20. Grunewald M et al. (2006) VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell 124: 175-189
21. Yamaguchi J et al. (2003) Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 107: 1322-1328
22. Davis ME et al. (2006) Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction. Proc Natl Acad Sci USA 103: 8155-8160
23. + cell proliferation and differentiation. Circ Res 97: E73-83